A 12-fold increase of miR155 expression level was observed following EGF treatment, but no change was found for miR200c, which had been reported to be downregulated in pancreatic cancer and other solid tumours [16], [17]. This evidence concerns the gene EGF and familial pancreatic carcinoma.